ArticleBMC infectious diseases2025
Pneumonia caused by Actinobacillus ureae in an immunocompetent healthy young male: a case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundActinobacillus ureae is a commensal found in the respiratory tract of humans. It is known to cause infections such as meningitis and septic arthritis in immunocompromised patients and also pneumonia especially in those with underlying chronic respiratory diseases. CASE REPORT: We report a case of right lower lobe pneumonia in a 15-year-old immunocompetent male who did not have any chronic illness including respiratory disease. Sputum analysis showed Gram-negative bacilli initially identified as Haemophilus ducreyi based on conventional biochemical tests. Later the organism was confirmed by VITEK® 2 COMPACT to be A. ureae. The patient was treated successfully with intravenous ceftriaxone followed by oral cefixime and doxycycline. Immunodeficiency, chronic illness, or significant environmental exposures except for frequent use of swimming pools and locker rooms were absent. It was hypothesised that he would have acquired the infection at these moist environments.
conclusionThe case underscores the need for heightened clinical awareness of rare pathogens, particularly in atypical presentations, and emphasizes the importance of advanced tests even in resource-limited settings. Hygiene in swimming pools and similar environments must be prioritized to prevent such infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.